Understanding the host in the management of pneumonia: An official American thoracic society workshop report

Medicine and Dentistry

• Pneumonia 100%
• Host 100%
• Comprehension 100%
• Diseases 25%
• Lung Infection 25%
• Development 16%
• Biological Marker 8%
• Health Outcomes 8%
• Immune Response 8%
• Phenotype 8%
• Pathogenesis 8%
• Combination Therapy 8%
• Sepsis 8%
• Immunosuppressive Drug 8%
• Respiratory Disease 8%
• Immunocompromised Patient 8%
• Lung Tuberculosis 8%
• Attention 8%
• Age 8%
• Critical Illness 8%
• Therapeutic Procedure 8%
• Consensus 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Pneumonia 100%
• Host 100%
• Diseases 25%
• Lung Infection 25%
• Clinical Study 16%
• Clinical Trial 16%
• Biological Marker 8%
• Sepsis 8%
• Pathogenesis 8%
• Immunocompromised Patient 8%
• Immunosuppressive Agent 8%
• Lung Tuberculosis 8%
• Respiratory Tract Disease 8%
• Critical Illness 8%